Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction

Beneficial Microbes

Volumn 5, Issue 4, 2014, Pages 397-402

  Sadowska Krawczenko, I ^a,b   Paprzycka, M ^b   Korbal, P ^b   Wiatrzyk, A ^c   Krysztopa Grzybowska, K ^c   Polak, M ^c   Czajka, U ^c   Lutynska A ^c  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b University Hospital No 2   (Poland)

^c NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Infection; Lactobacillus rhamnosus; Neonatal; Probiotics

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFOTAXIME; IMIPENEM; RNA 16S; TIMENTIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; PROBIOTIC AGENT; RIBOSOME DNA;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DNA FINGERPRINTING; GENETIC SIMILARITY; GENOTYPING TECHNIQUE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LACTOBACILLUS RHAMNOSUS; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; RNA SEQUENCE; TREATMENT DURATION; ADOLESCENT; BLOOD; CHEMISTRY; DNA SEQUENCE; FEMALE; GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING;

ADOLESCENT; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTI-BACTERIAL AGENTS; BLOOD; C-REACTIVE PROTEIN; DNA, BACTERIAL; DNA, RIBOSOMAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; LACTOBACILLUS RHAMNOSUS; MALE; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PROBIOTICS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84907030408     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0074     Document Type: Article

References (23)

1. Allen, S.J., Martinez, E.G., Gregorio, G.V. and Dans, L.F., 2010. Probiotics for treating acute infectious diarrhoea. Cochrane Database of Systematic Reviews 10, CD003048.
2. Boyle, R.J., Robins-Browne, R.M. and Tang, M.L., 2006. Probiotic use in clinical practice: what are the risks? American Journal of Clinical Nutrition 83: 1256-1264.
3. Brandt, K. and Alatossava, T., 2003. Specific identification of certain probiotic Lactobacillus rhamnosus strains with PCR primers based on phage-related sequences. International Journal of Food Microbiology 84: 189-196.
4. Cabana, M.D., Shane, A.L., Chao, C. and Oliva-Hemker, M., 2006. Probiotics in primary care pediatrics. Clinical Pediatrics 45: 405-410.
5. Coudeyras, S., Marchandin, H., Fajon, C. and Forestier, C., 2008. Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group. Applied and Environmental Microbiology 74: 2679-2689.
6. Guarino, A., Albano, F., Ashkenazi, S., Gendrel, D., Hoekstra, J.H., Shamir, R., Szajewska, H. and ESPGHAN/ESPID Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe Expert Working Group, 2008. European Society for paediatric gastroenterology, hepatology, and nutrition/european society for paediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: executive summary. Journal of Pediatric Gastroenterology and Nutrition 46: 619-621.
7. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
8. Kochan, P., Chmielarczyk, A., Szymaniak, L., Brykczynski, M., Galant, K., Zych, A., Pakosz, K., Giedrys-Kalemba, S., Lenouvel, E. and Heczko, P.B., 2011. Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient--is the time right to revise probiotic safety guidelines? Clinical Microbiology and Infection 17: 1589-1592.
9. Kokotovic, B., Friis, N.F., Jensen, J.S. and Ahrens, P., 1999. Amplified fragment length polymorphism fingerprinting of Mycoplasma species. Journal of Clinical Microbiology 37: 3300-3307.
10. LGG Multicenter Study Group, 2002. A multicenter, placebo-controlled, double-blind study of Lactobacillus GG in addition to maintenance therapy in children with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition 35: 404-406.
11. Liong, M.T., 2008. Safety of probiotics: translocation and infection. Nutrition Reviews 66: 192-202.
12. Manzoni, P., Lista, G., Gallo, E., Marangione, P., Priolo, C., Fontana, P., Guardione, R. and Farina, D., 2011. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Human Development 87 Suppl. 1: S35-S38.
13. Maro´di, L., 2006. Innate cellular immune responses in newborns. Clinical Immunology 118: 137-144.
14. Mastretta, E., Longo, P., Laccisaglia, A., Balbo, L., Russo, R., Mazzaccara, A. and Gianino, P., 2002. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. Journal of Pediatric Gastroenterology and Nutrition 35: 527-531.
15. Mugambi, M.N., Musekiwa, A., Lombard, M., Young, T. and Blaauw, R., 2012. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutrition Journal 11: 81.
16. Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V. and Ja¨rvinen, A., 2004. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clinical Infectious Diseases 38: 62-69.
17. Salminen, M.K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V. and Ja¨rvinen, A., 2002. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 35: 1155-1160.
18. Saxelin, M., 1997. Lactobacillus GG - a human probiotic strain with thorough clinical documentation. Food Reviews International 13: 293-313.
19. Song, Y., Kato, N., Liu, C., Matsumiya, Y., Kato, H. and Watanabe, K., 2000. Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA. FEMS Microbiology Letters 187: 167-173.
20. Szajewska, H., Sko´rka, A. and Dylag, M., 2007. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Alimentary Pharmacology and Therapeutics 25: 257-264.
21. Thomas, D.W., Greer, F.R. and Committee on nutrition, section on gastroenterology, hepatology, and nutrition, 2010. Probiotics and prebiotics in pediatrics. Pediatrics 126: 1217-1231.
22. Van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F. and Brummer, R.J. 2014. Probiotic and synbiotic safety in infants under two years of age. Beneficial Microbes 5: 45-60.
23. Van Eldere, J., Janssen, P., Hoefnagels-Schuermans, A., Van Lierde, S. and Peetermans, W.E., 1999. Amplified-fragment length polymorphism analysis versus macro-restriction fragment analysis for molecular typing of Streptococcus pneumoniae isolates. Journal of Clinical Microbiology 37: 2053-2057.